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Abstract: Splenic artery aneurysms (SAAs) are a rare arterial disease (1) and defined as a diameter of more than 50% of
expected (0.9 - 1 cm) splenic artery diameter. They account for 60-70% of visceral artery aneurysms making them the
most common of this group (4). They are often difficult to diagnose due to their vague or non-existing symptoms but
present a high risk of rupture in certain patient groups making this a clinically important differential diagnosis.
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SAA may be true or false (pseudo-SAA). True
aneurysms account for 60% of SAAs and affect women
four times more than men and are seen in the 5th and 6th
decades of life[1,3,4]. True SAA risk factors are
hypertension, atherosclerosis, smoking, cirrhosis, portal
hypertension, liver transplantation, female sex and
multiparity[1-4]. Less common risk factors include
splenomegaly, collagen vascular disease, inflammatory
conditions (SLE, polyarteritis nodosa), and anomalous
splenic artery origin. Pseudo-SAAs occur more often in
men and are most commonly due to acute or chronic
pancreatitis, pancreatic pseudocyst and trauma[1,4].
SAAs are frequently missed or have a delayed
diagnosis due to nonspecific or lack of clinical symptoms.
An estimated 80% are asymptomatic and therefore
incidentally diagnosed. Non-specific symptoms include
epigastric or left upper quadrant pain, nausea, vomiting
or anorexia[1,4]. Life-threatening complications of SAA
are spontaneous rupture, fistulisation (stomach,
duodenum, colon, pancreatic duct, pancreatic
pseudocyst), and formation of an arterio-venous fistula[4].
Some 2-10% of patients will present with spontaneous
rupture with a mortality of 10-40% (4). These patients
may present with sudden on-set sharp left upper quadrant
or epigastric pain, left shoulder tip pain, and
haemodynamic instability[1,4]. 95% of ruptures occur in
pregnancy (especially in the 3rd trimester) with a
maternal and foetal mortality rate of 75% and 90%.
Pregnancy itself presents a 24% risk of spontaneous SAA
rupture[1,3,4]. Other high–risk groups are clinically
symptomatic SAAs, diameter >2cm, increase in diameter,
portal hypertension, liver transplantation and surgical
treatments affecting portal system pressure[1,3,4]. There is
some evidence of an inverse relationship between the
amount of calcification and size of the aneurysm and
therefore the risk of rupture[1]. Pseudo-SAAs have a
significantly higher risk of rupture at 37% with a
spontaneous rupture mortality rate of almost 100%[1,4].
The radiological diagnosis of an SAA may be made
with abdominal ultrasound as an anechoic mass with or
without peripheral calcification or on a CT angiography.
MRI/MRA will better show smaller aneurysms with the
added benefit of no radiation exposure. Digital
Subtraction Angiography (DSA) is the gold-standard and
identifies the exact location of the SAA as well as
dynamic evidence of bleeding[1,4].
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Although it is invasive, DSA carries the
added benefit of endovascular treatment in the acute
setting[1,4].
It is generally agreed that incidentally found
SAAs >2 cm or enlarging in high-risk groups (pregnant
or likely to become pregnant women, liver transplant,
portal hypertension), and in symptomatic patients
regardless of size require treatment (1, 4). No consensus
currently exists for the management of asymptomatic
<2cm SAAs. Risk factor modification for peripheral
arterial disease with lifestyle changes, smoking cessation,
antiplatelets, antihypertensives and statins has been
offered and seems logical but the evidence is poor[4]. One
of the largest case series (128 patients) suggests that
small (<2cm), heavily calcified and asymptomatic SAAs
could be serially imaged or even discharged as they have
a negligible risk of rupture[2]. It is widely agreed that
splenic pseudoaneurysms should always be treated
urgently as the risk of rupture is nearly 100%[1] and
endovascular surgery is now the treatment of choice.
Surveillance should be offered lifelong post liver
transplantation but there is no consensus for follow-up of
previously treated patients or conservatively managed
patients with some having 6 monthly or yearly
imaging[1].
Figure 1. A CT angiogram showing a 2.8 cm splenic artery
aneurysm.
There are a variety of treatment options and
selection will depend on patient and anatomical factors
as well as local expertise. Laparoscopic and
endovascular (embolisation, coiling or stenting) surgery
have largely replaced open surgery (ligation or
reconstruction)[1], however there still remains limited
long-term data for endovascular treatments. Open
surgery is now largely relegated to ruptures with
haemodynamic instability[1].
SAAs are a clinically important differential
diagnosis to consider in certain patient groups. Their
management remains controversial and may require the
combined expertise of the vascular, radiology and upper
GI surgery services. When incidentally found, they
should be referred for evaluation and vascular MDT
discussion. When presenting with complications, surgical
input should be sought and ultimate treatment will
depend on the exact nature of the complication.
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